Tryp Therapeutics Inc buy jomobb
Start price
16.05.21
/
80%
€0.45
Target price
16.05.22
€0.70
Performance (%)
-68.29%
End price
29.01.22
€0.14
Summary
This prediction ended on 29.01.22 with a price of €0.14. The BUY prediction by jomobb for Tryp Therapeutics Inc performed very badly with a performance of -68.29%. jomobb has 80% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y | 3y |
---|---|---|---|---|
Tryp Therapeutics Inc | - | - | - | - |
iShares Core DAX® | 2.821% | -1.953% | 15.071% | 11.862% |
iShares Nasdaq 100 | 5.285% | -5.092% | 29.254% | 40.075% |
iShares Nikkei 225® | 3.687% | -4.221% | 14.286% | 6.629% |
iShares S&P 500 | 3.577% | -2.240% | 25.546% | 38.398% |
According to jomobb what are the pros and cons of Tryp Therapeutics Inc for the foreseeable future?
Pros
Could be very worthwhile Investment >20% year
Capable Management
Leading role in innovation
Some uniques
Differentiated customer and product portfolio
Very Future proof/growth oriented business model
Top 10 in its market
Cons
Very high cyclical dependencies
Comments by jomobb for this prediction
In the thread Tryp Therapeutics Inc diskutieren
Buy mit Kursziel 0,0
Kursziel geändert auf 0,7